The Efficacy of First-Generation EGFR-TKI Combined With Brain Radiotherapy as the First-Line Treatment for Lung Adenocarcinoma Patients With Brain Metastases and EGFR Sensitive Mutations: A Retrospective study

The Efficacy of First-Generation EGFR-TKI Combined With Brain Radiotherapy as the First-Line Treatment for Lung Adenocarcinoma Patients With Brain Metastases and EGFR Sensitive Mutations: A Retrospective study

Background: It was controversial that whether LUAD patients with brain metastases (BMs) and EGFR sensitive mutations should be conducted using brain radiotherapy when treated with first-generation EGFR-TKI. Herein, a retrospective study was designed to compare the efficacy of first-generation EGFR-T...

Full description

Bibliographic Details
Main Authors: Yuting Liu MD, Juanjuan Wang MD, Jingjing Wu MD, Qifan Yang MD, Yulan Zeng MD, Di Wu MD, Chen Tian MD, Yue Hu MD, PhD, Feifei Gu MD, PhD, Chang Li MD, Kai Zhang MD, PhD, Li Liu MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2021-03-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/1533033821997819

Internet

https://doi.org/10.1177/1533033821997819

Similar Items